marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2022-Q3
added 11-14-2022
LogicBio Therapeutics Financial Ratios 2011-2024 | LOGC
Annual Financial Ratios LogicBio Therapeutics
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.6 | -5.8 | -5.6 | -2.9 | - | - | - | - | - | - | - |
P/S |
12.0 | 55.1 | - | - | - | - | - | - | - | - | - |
EPS |
-1.2 | -1.3 | -1.8 | -3.0 | -5.5 | - | - | - | - | - | - |
EV (Enterprise Value) |
43.3 M | 139 M | 206 M | -27.3 M | 10.2 M | 5.28 M | - | - | - | - | - |
EBITDA per Share |
-1.18 | -1.32 | -1.8 | -3.08 | - | - | - | - | - | - | - |
EV/EBITDA |
-1.1 | -4.2 | -5.0 | 1.7 | - | - | - | - | - | - | - |
PEG |
- | -0.31 | -0.14 | 0.01 | - | - | - | - | - | - | - |
P/B |
2.1 | 3.1 | 5.3 | 0.6 | - | - | - | - | - | - | - |
P/CF |
-3.4 | -6.5 | -5.6 | -3.2 | - | - | - | - | - | - | - |
ROE % |
-130.27 | -53.11 | -94.89 | -21.96 | - | - | - | - | - | - | - |
ROA % |
-63.77 | -40.45 | -72.09 | -21.25 | - | - | - | - | - | - | - |
ROCE % |
-126.88 | -42.30 | -78.78 | -22.37 | - | - | - | - | - | - | - |
Current Ratio |
2.0 | 11.8 | 14.8 | 30.6 | - | - | - | - | - | - | - |
DSO |
9.9 | 27.8 | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
9.9 | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
9.9 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios LogicBio Therapeutics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | -0.18 | -0.15 | -0.2 | - | -0.31 | -0.33 | -0.32 | - | -0.34 | -0.35 | -0.41 | - | -0.48 | -0.45 | -0.34 | - | -4.03 | -4.19 | -2.75 | - | -1.55 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | -0.16 | -0.14 | -0.19 | - | -0.29 | -0.31 | -0.31 | - | -0.31 | -0.33 | -0.4 | - | -0.48 | -0.46 | -0.36 | - | -2.11 | -1.84 | -1.32 | - | -0.69 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-87.78 | -114.06 | -103.64 | -102.72 | -68.66 | -81.75 | -68.56 | -58.53 | -41.87 | -67.69 | -80.42 | -90.79 | -144.47 | -150.29 | -130.30 | -111.01 | -13.16 | -1.02 | 16.94 | 21.41 | 12.14 | 12.14 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-38.53 | -53.46 | -53.44 | -56.19 | -42.33 | -52.30 | -47.33 | -44.05 | -31.90 | -51.51 | -61.16 | -69.01 | -109.76 | -115.39 | -101.41 | -87.68 | -12.74 | -16.73 | -15.08 | -10.76 | -3.99 | -3.99 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-86.00 | -111.65 | -100.80 | -99.99 | -66.93 | -79.57 | -66.56 | -56.72 | -40.81 | -66.90 | -80.35 | -92.12 | -70.02 | -75.69 | -55.27 | -35.08 | -13.17 | -0.96 | 16.92 | 21.46 | 12.21 | 12.21 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | 1.7 | 1.8 | 1.9 | 2.0 | 2.3 | 2.4 | 3.8 | 4.2 | 4.2 | 4.2 | 4.2 | 4.2 | 4.2 | 4.2 | 4.2 | 30.9 | 30.9 | - | 30.9 | 15.3 | 15.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | 0.5 | - | 4.2 | 9.4 | 34.8 | - | 25.9 | 24.9 | 11.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | 0.5 | - | 4.2 | 9.4 | 34.8 | - | 25.9 | 24.9 | 11.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | 0.5 | - | 4.2 | 9.4 | 34.8 | - | 25.9 | 24.9 | 11.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency